Dihydromyricetin Attenuates Metabolic Syndrome And Improves Insulin Sensitivity By Upregulating Insulin Receptor Substrate-1 (Y612) Tyrosine Phosphorylation In db/db Mice

Dihydromyricetin Attenuates Metabolic Syndrome And Improves Insulin Sensitivity By Upregulating Insulin Receptor Substrate-1 (Y612) Tyrosine Phosphorylation In db/db Mice

Jidong He,1 Junpeng Zhang,1 Lijuan Dong,1 Xuefeng Dang,1 Li Wang,2 Long Cheng,3 Yunxiang Huang4 1Department of Gastroenterology, Baoji People’s Hospital, Baoji, Shanxi 721000, People’s Republic of China; 2Department of Diabetic Nephropathy, Baoji Central Hospital, Baoji, Shanxi 7...

Full description

Bibliographic Details
Main Authors: He J, Zhang J, Dong L, Dang X, Wang L, Cheng L, Huang Y
Format: Article
Language:English
Published: Dove Medical Press 2019-11-01
Series:Diabetes, Metabolic Syndrome and Obesity
Subjects:
dihydromyricetin
metabolic syndrome
hypoglycemic function
insulin resistance
insulin receptor substrate-1
Online Access:https://www.dovepress.com/dihydromyricetin-attenuates-metabolic-syndrome-and-improves-insulin-se-peer-reviewed-article-DMSO

Internet

https://www.dovepress.com/dihydromyricetin-attenuates-metabolic-syndrome-and-improves-insulin-se-peer-reviewed-article-DMSO

Similar Items